We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$11.9B
AUM Growth
+$2.85B
Cap. Flow
+$2.52B
Cap. Flow %
21.15%
Top 10 Hldgs %
66.56%
Holding
140
New
48
Increased
33
Reduced
16
Closed
39

Sector Composition

Rank Sector Weight
1 Industrials 11.86%
2 Materials 9.38%
3 Healthcare 8.13%
4 Energy 7.96%
5 Technology 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
126
DELISTED
Altair Engineering Inc
ALTR
-69,362
Closed -$7.57M
EDR
127
DELISTED
Endeavor Group Holdings, Inc.
EDR
-15,121,666
Closed -$473M
EDR
128
PUT
DELISTED
Endeavor Group Holdings, Inc.
EDR
-1,117,000
Closed -$35M
AZPN
129
DELISTED
Aspen Technology Inc
AZPN
-38,000
Closed -$9.49M
ALTM
130
DELISTED
Arcadium Lithium plc
ALTM
-27,550,000
Closed -$141M
ALTM
131
PUT
DELISTED
Arcadium Lithium plc
ALTM
-400,000
Closed -$2.05M
HCP
132
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-478,484
Closed -$16.4M
SILV
133
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-997,000
Closed -$9.07M
SUM
134
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-200,000
Closed -$10.1M
ENLC
135
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
-2,575,000
Closed -$36.4M
B
136
DELISTED
Barnes Group Inc.
B
-110,000
Closed -$5.2M
SMAR
137
DELISTED
Smartsheet Inc.
SMAR
-8,950,000
Closed -$501M
PSTX
138
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-8,625,000
Closed -$82.8M
ML
139
DELISTED
MoneyLion Inc.
ML
-5,000
Closed -$430K

Similar funds

Pentwater Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Pentwater Capital Management held 140 positions worth $11.9B, up 31% from $9.06B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Pentwater Capital Management deployed $2.52B of net new capital in Q1 2025, opening 48 new positions and adding to 33 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 9.2% a quarter earlier, followed by Materials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.2M trimmed.

  • Pentwater Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 5,190,000 shares worth $685M.
  • Pentwater Capital Management added most to Kellanova in Q1 2025, an estimated $184M increase.
  • Pentwater Capital Management's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.2M.
  • Pentwater Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $501M.
  • Pentwater Capital Management's ten largest holdings make up 67% of its $11.9B portfolio in Q1 2025.
  • Pentwater Capital Management opened 48 new positions and closed 39 in Q1 2025.
  • Pentwater Capital Management's portfolio value rose 31% quarter-over-quarter to $11.9B.

Based on Pentwater Capital Management's 13F filing for Q1 2025, filed 15 May 2025.